Outcomes of Head and Neck Microvascular Reconstruction in Hypercoagulable PatientsFunding None.
17 May 2019
28 October 2019
13 December 2019 (online)
Background Inherited coagulopathies and previous thrombotic events are often considered relative contraindications to microvascular reconstruction. We hypothesize that with planning, head and neck microvascular reconstruction can be successfully performed in hypercoagulable individuals.
Methods A retrospective review was conducted of subjects with coagulopathies or previous thrombotic events who underwent microvascular head and neck reconstruction. Outcomes studied were “flap-related complications” (arterial/venous compromise or flap loss) and “patient-related complications” (hematoma, deep venous thrombosis, pulmonary embolism, infection, stroke, or death).
Results One hundred thirty-four microvascular flaps were performed in 117 subjects. Twenty-four subjects (20.5%) had a preoperative hypercoagulable condition and underwent 28 microvascular reconstructions. Twenty-three of 24 subjects had a previous thrombotic event, with five subjects identified with an inherited or acquired coagulopathy. All microvascular reconstructions were successful; however, complications occurred in 12 of 28 reconstructions (42.9%). Complications were “flap related” in four reconstructions (14.3%), “patient related” in nine reconstructions (32.1%), and both in one reconstruction (3.6%). Flap-related complications included small partial flap loss (n = 2), arterial compromise (n = 1), and venous compromise (n = 1), with all undergoing successful salvage. Patient-related complications included hematoma (n = 3), pulmonary embolism (n = 2), infection (n = 2), deep venous thrombosis (n = 1), and death (n = 1). Statistical analysis demonstrated that complications were more common in subjects with inferior vena cava filters (p = 0.06) and hematomas were associated with the use of therapeutic heparin infusion (p = 0.04).
Conclusion Microvascular head and neck reconstruction can be successfully performed in hypercoagulable subjects. However, patient-related complications remain a concern in these subjects.
Keywordsthrombophilia - hypercoagulation - thrombosis - anticoagulation - microvascular reconstruction - microvascular flaps
This study was presented at the American Society for Reconstructive Microsurgery Annual Meeting 2019, Palm Desert, California.
- 1 Zöller B, García de Frutos P, Hillarp A, Dahlbäck B. Thrombophilia as a multigenic disease. Haematologica 1999; 84 (01) 59-70
- 2 Di Minno MN, Ambrosino P, Ageno W, Rosendaal F, Di Minno G, Dentali F. Natural anticoagulants deficiency and the risk of venous thromboembolism: a meta-analysis of observational studies. Thromb Res 2015; 135 (05) 923-932
- 3 Wang TY, Serletti JM, Cuker A. , et al. Free tissue transfer in the hypercoagulable patient: a review of 58 flaps. Plast Reconstr Surg 2012; 129 (02) 443-453
- 4 DeFazio MV, Hung RW, Han KD, Bunting HA, Evans KK. Lower extremity flap salvage in thrombophilic patients: managing expectations in the setting of microvascular thrombosis. J Reconstr Microsurg 2016; 32 (06) 431-444
- 5 Langer S, Munder B, Seidenstuecker K. , et al. Development of a surgical algorithm and optimized management of complications - based on a review of 706 abdominal free flaps for breast reconstruction. Med Sci Monit 2010; 16 (11) CR518-CR522
- 6 Fisher JL, Palmisano S, Schwartzbaum JA, Svensson T, Lönn S. Comorbid conditions associated with glioblastoma. J Neurooncol 2014; 116 (03) 585-591
- 7 Bui DT, Cordeiro PG, Hu QY, Disa JJ, Pusic A, Mehrara BJ. Free flap reexploration: indications, treatment, and outcomes in 1193 free flaps. Plast Reconstr Surg 2007; 119 (07) 2092-2100
- 8 Khouri RK. Avoiding free flap failure. Clin Plast Surg 1992; 19 (04) 773-781
- 9 Khouri RK, Cooley BC, Kunselman AR. , et al. A prospective study of microvascular free-flap surgery and outcome. Plast Reconstr Surg 1998; 102 (03) 711-721
- 10 Davison SP, Kessler CM, Al-Attar A. Microvascular free flap failure caused by unrecognized hypercoagulability. Plast Reconstr Surg 2009; 124 (02) 490-495
- 11 Srikanthan K, Viswanathan N, Yuen JC. Free-flap failure in thrombophilia: case report and systematic review of the literature. Ann Plast Surg 2013; 71 (06) 675-681
- 12 ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Thromb Res 2014; 134 (05) 931-938
- 13 Dave PA. Heparin-induced thrombocytopaenia/thrombosis: a clinicopathologic review. East Afr Med J 2009; 86 (12, Suppl): S62-S70
- 14 Ahmed I, Majeed A, Powell R. Heparin induced thrombocytopenia: diagnosis and management update. Postgrad Med J 2007; 83 (983) 575-582
- 15 DeFazio MV, Economides JM, Anghel EL, Tefera EA, Evans KK. lower extremity free tissue transfer in the setting of thrombophilia: analysis of perioperative anticoagulation protocols and predictors of flap failure. J Reconstr Microsurg 2018
- 16 Heit JA. Thrombophilia: common questions on laboratory assessment and management. Hematology Am Soc Hematol Educ Program 2007; (01) 127-135
- 17 Zavlin D, Chegireddy V, Jubbal KT, Agrawal NA, Spiegel AJ. Management of microsurgical patients using intraoperative unfractionated heparin and thromboelastography. J Reconstr Microsurg 2019; 35 (03) 198-208